JHJingwen Huang

Jingwen Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jingwen Huang has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Min Zhou

    Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine

    4 shared publications
  • Jieming Qu

    Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    2 shared publications
  • Lingxi Guo

    Science and Technology on Space Physics Laboratory, Beijing 100076, China

    2 shared publications
  • Min Zhou

    Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, People’s Republic of China

    2 shared publications
  • Rong Chen

    Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

    2 shared publications
  • Bing Liu

    Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Clinical and Microbiological Characteristics of Pulmonary Aspergillosis in Elderly vs Non-Elderly Patients: A tNGS-Based Retrospective Study

    by Miao Yu, Qianqian Zhao, Jingwen Huang, Jiaxin Tian, Xuefei Liu, Simin Xie, Chao Sun, Yijie Li, Wanjie Xu, Fengfei Qian, et al.

    Background: Elderly patients are more susceptible to pulmonary aspergillosis(PA) and exhibit worse clinical outcomes. This study aims to compare the clinical characteristics, pathogen distribution, co-infection patterns, and outcomes of elderly and non-elderly patients with PA diagnosed via targeted next-generation sequencing (tNGS). Methods: This retrospective study included 107 patients with tNGS-confirmed pulmonary aspergillosis admitted to Ruijin Hospital between March 2023 and January 2025. Demographic, clinical, radiological, and laboratory data were extracted from electronic medical records to compare the clinical and microbiological profiles between the elderly (≥ 65 years) and non-elderly (< 65 years) cohorts. Results: A total of 107 patients including elderly (n=64) and non-elderly (n=43) were included retrospectively. The prevalence of invasive pulmonary aspergillosis was significantly higher in the elderly group compared to the non-elderly group (93.8% vs 74.4%). Similarly, the elderly group had significantly higher proportions of overall co-infection (79.7% vs 51.2%), bacterial co-infection (68.8% vs 39.5%), and atypical imaging features such as patchy infiltrates/consolidation (89.1% vs 62.8%) (all P < 0.05). Furthermore, the elderly exhibited significantly lower lymphocyte and albumin levels, and higher D-dimer levels (P < 0.05). Mortality was also significantly higher among elderly patients (18.8% vs 4.7%; P = 0.042). Conclusion: Within our study scope, pulmonary aspergillosis in the elderly is characterized by higher mortality, atypical imaging, prevalent bacterial co-infections, and specific laboratory deviations—most notably, diminished lymphocytes and albumin alongside elevated D-dimer and LDH levels. Furthermore, tNGS serves as a valuable adjunctive tool to identify complex mixed pathogens and assist in clinical management.

  • Open Access

    Risk of extended viral shedding of Omicron BA.2 in Shanghai: Implications for vaccination strategy optimization

    by Jingwen Huang, Lin Huang, Jing Xi, Yong Li, Jianping Zhou, Zhiyao Bao, Qijian Cheng, Qingyun Li, Min Zhou, Ren Zhao, et al.


  • A Case Study on the Internal Mutual Interference of Multitenant FPGA

    by Jingwen Huang, Qinming Zhou, Chiayi Kuo, Weicong Lu, Tao Su

    Previous researches have shown that a remote user can cause the circuit of another user in a cloud FPGA to fail by creating mutual interference inside the FPGA. However, the fundamental mechanism of mutual interference is still not clear. This paper conducts a series of tests to investigate the condition and the type of the function failure. Two critical parameters of the interference source, the number of interference units $({N}_{INT})$ and the frequency of the interference $({f}_{INT})$ are examined. The behavior of a microprocessor is monitored at the instruction level during the interference experiments. Our test results show that ${N}_{INT}$ is inversely proportional to ${f}_{INT}$ at the failure threshold. The relationship indicates that the deciding factor of interference source on the failure of the microprocessor is the average current. The ratio of interference frequency to microprocessor frequency plays no role in the failure threshold. It is observed that the malfunctions of the program count (PC) and the instructions are the main reasons for the system failure. The interference also causes the pipeline to stall. The results presented in this paper help to understand the bottom mechanism of FPGA failure under remote attack. It also helps to make countermeasures to protect the FPGA.

  • Open Access

    Absolute Neutrophil Count in the Peripheral Blood Predicts Prognosis in Lung Cancer Patients Treated with Anlotinib

    by Rong Chen, Fang-Ying Lu, Bing Liu, Jingwen Huang, Min Zhou, Ranran Dai, Yi Guo

    Purpose: Anlotinib is a multi-targeted tyrosine kinase inhibitor that inhibits tumor angiogenesis and cell proliferation. It is widely used as a third-line therapy for lung cancer. However, reliable prognostic biomarkers for predicting the efficacy of anlotinib are lacking. We conducted a retrospective study to investigate the prognostic value of serological inflammatory biomarkers in anlotinib treatment. Patients and Methods: Patients with advanced lung cancer treated with anlotinib monotherapy were enrolled. Cox regression was conducted to analyze the significant factors related to progression-free survival (PFS) and overall survival (OS). The objective response rate (ORR) was compared based on the median cut-off value of the significant inflammation index. Meanwhile, we created survival curves to compare the two groups and performed receiver operating characteristic curve analysis to assess the predictive ability of the inflammation index. Results: Among a total of 71 patients, the median PFS was 5.5 months and the median OS was 9.5 months. The ORR and disease control rate were 16.9% and 84.5%, respectively. According to univariate and multivariate analyses, absolute neutrophil count (ANC) was the only indicator associated with both PFS (hazard ratio [HR] =1.095, 95% confidence interval [CI] 1.030– 1.163, P=0.003) and OS (HR=1.057, 95% CI 1.003– 1.113, P=0.037). In the group with ANC ≥ 4.58, the ORR was relatively lower (8.1% vs 26.5%, P=0.057), but not statistically significant; PFS and OS were relatively shorter (median PFS 5.0 [95% CI 4.4– 9.6] vs 7.0 months [95% CI 4.4– 5.7], P=0.024 and median OS 7.3 [95% CI 4.7– 10.0] vs 17.6 months [95% CI 12.3– 22.9], P < 0.001). ANC had a relatively high discriminatory ability to predict 10-month survival, with an area under the curve of 0.729, sensitivity of 82.5%, and specificity of 67.7%. Conclusion: Elevated pre-treatment ANC was associated with a poor prognosis. Patients with lower peripheral blood levels of ANC might benefit from anlotinib.


  • Open Access

    Identification of distinct metabolic characteristics of pneumonia in type 2 diabetes mellitus

    by Jingwen Huang, Ying Xie, Daoyi Yuan, Lingxi Guo, Jieming Qu, Min Zhou


  • Open Access

    The mNCP-SPI Score Predicting Risk of Severe COVID-19 among Mild-Pneumonia Patients on Admission

    by Lingxi Guo, Weining Xiong, Dong Liu, Yun Feng, Peng Wang, Xuan Dong, Rong Chen, Yi Wang, Lei Zhang, Jingwen Huang, et al.

    Purpose: To predict the risk of developing severe pneumonia among mild novel coronavirus pneumonia (mNCP) patients on admission. Methods: A retrospective cohort study was conducted at three hospitals in Shanghai and Wuhan from January 2020 to February 2020. Real-time polymerasechain–reaction assays were used to detect COVID-19. A total of 529 patients diagnosed with NCP were recruited from three hospitals and classified by four severity types during hospitalization following the standards of the Chinese Diagnosis and Treatment of Pneumonia Caused by New Coronavirus Infection (eighth version). Patients were excluded if admitted by ICU on admission (n=92, on a general ward while meeting the condition of severe or critical type on admission (n=25), or there was insufficient clinical information (n=64). In sum, 348 patients with mNCP were finally included, and 68 developed severe pneumonia. Results: mNCP severity prognostic index values were calculated based on multivariate logistic regression: history of diabetes (OR 2.064, 95% CI 1.010– 4.683; p=0.043), time from symptom onset to admission ≥ 7 days (OR 1.945, 95% CI 1.054– 3.587; p=0.033), lymphocyte count ≤ 0.8 (OR 1.816, 95% CI 1.008– 3.274; p=0.047), myoglobin ≥ 90 mg/L (OR 2.496, 95% CI 1.235– 5.047; p=0.011), and D-dimer ≥ 0.5 mg/L (OR 2.740, 95% CI 1.395– 5.380; p=0.003). This model showed a c-statistics of 0.747, with sensitivity and specificity 0.764 and 0.644, respectively, under cutoff of 165. Conclusion: We designed a clinical predictive tool for risk of severe pneumonia among mNCP patients to provided guidance for medicines. Further studies are required for external validation.


  • Open Access

    Validation of the brief international classification of functioning, disability, and health core set for obstructive pulmonary disease in the Chinese context

    by Jingwen Huang, Jan D Reinhardt, Ranran Dai, Pu Wang, Min Zhou

    In order to determine the validity of the International Classification of Functioning, Disability, and Health brief Core Set for Obstructive Pulmonary Disease (ICF-OPD) for the assessment of functioning and environmental factors in Chinese chronic OPD (COPD) patients, we conducted a cross-sectional study with a convenience sample of 100 COPD patients. Data were collected using common questionnaires for COPD patients (Modified British Medical Research Council Questionnaire, COPD Assessment Test, St George’s Respiratory Questionnaire (SGRQ)), the Brief ICF Core Set for OPD, and the comprehensive ICF checklist. All except one category of the Brief ICF-OPD Core Set were confirmed in our evaluation of its content validity, but there is a high prevalence of problems in 8 categories that were not considered in the Brief ICF-OPD Core Set. The functioning-related components of the Brief ICF-OPD Core Set largely performed similarly to SGRQ in terms of differentiating between patients with different disease severity. Moreover, high correlations between the Brief ICF-OPD Core Set overall score and component scores with the respective SGRQ scales and moderate correlations between ICF-OPD Core Set overall score and component scores and lung function parameters. This study largely confirmed content, known group, and convergent validity of the ICF-OPD.